Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1275 of 3173 entries
View as:

CP-690-550 Ointment For Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01246583 Org: User:
Start: 02/16/11 End: 11/29/11 Due: 11/29/12

Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.

Phase: N/A Priority: Normal
NCT ID: NCT04748445 Org: User:
Start: 04/12/21 End: 04/22/22 Due: 04/22/23

The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01962207 Org: User:
Start: 10/31/13 End: 06/30/18 Due: 06/30/19

Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

Phase: N/A Priority: Normal
NCT ID: NCT00150449 Org: User:
Start: 01/31/01 End: 03/31/06 Due: 03/31/07

A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS

Phase: N/A Priority: Normal
NCT ID: NCT00627003 Org: User:
Start: 11/30/02 End: 05/31/03 Due: 05/31/04

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Phase: N/A Priority: Normal
NCT ID: NCT00161941 Org: User:
Start: 06/30/03 End: 12/31/03 Due: 12/31/04

Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00143455 Org: User:
Start: 06/30/02 End: 12/31/08 Due: 12/31/09

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02228382 Org: User:
Start: 11/07/14 End: 10/13/20 Due: 10/13/21

A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT04092452 Org: User:
Start: 12/02/19 End: 01/10/22 Due: 01/10/23

Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00798304 Org: User:
Start: 01/31/09 End: 09/30/09 Due: 09/30/10

Topical CP-690,550 For Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00678561 Org: User:
Start: 10/13/08 End: 07/24/09 Due: 07/24/10

Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient

Phase: N/A Priority: Normal
NCT ID: NCT00263328 Org: User:
Start: 12/31/05 End: 06/30/14 Due: 06/30/15

Dose Escalation Study of PF-06741086 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02531815 Org: User:
Start: 08/31/15 End: 07/31/16 Due: 07/31/17

A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01564784 Org: User:
Start: 08/02/12 End: 01/04/17 Due: 01/04/18

Evaluation of Pharmacokinetic Drug Drug Interaction Between PF-05221304 And PF-06865571 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03534648 Org: User:
Start: 04/19/18 End: 08/29/18 Due: 08/29/19

A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05067439 Org: User:
Start: 10/21/21 End: 02/26/22 Due: 02/26/23

Post-Authorization Study Evaluating Safety Of Tigecycline

Phase: N/A Priority: Normal
NCT ID: NCT00827541 Org: User:
Start: 08/31/08 End: 12/31/10 Due: 12/31/11

Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00500266 Org: User:
Start: 05/31/08 End: 05/31/09 Due: 05/31/10

A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00220363 Org: User:
Start: 01/31/04 End: 02/28/05 Due: 02/28/06

Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture

Phase: N/A Priority: Normal
NCT ID: NCT00824564 Org: User:
Start: 04/30/09 End: 06/30/10 Due: 06/30/11

Tanezumab in Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT00733902 Org: User:
Start: 09/15/08 End: 01/14/10 Due: 01/14/11

Combination of Irinotecan and Temozolomide in Children With Brain Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT00404495 Org: User:
Start: 04/30/07 End: 12/31/11 Due: 12/31/12

A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00921063 Org: User:
Start: 11/30/05 End: 07/31/06 Due: 07/31/07

Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00609622 Org: User:
Start: 04/30/08 End: 07/31/11 Due: 07/31/12

A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT00138762 Org: User:
Start: 07/31/04 End: 08/31/06 Due: 08/31/07